References
- Li Volsi VA. Papillary thyroid carcinoma: An update. Mod Pathol. 2011; 24(2): S1-S9.
- Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors. J Cancer Epidemiol. 2013; 2013: 965212.
- Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011; 5(1): 51-56.
- De Groot LJ, Reed Larsen P, Hennemann G, Editors. The Thyroid and Its Diseases, 6th ed. New York, NY, USA: Churchill Livingstone, 1996.
- Burns WR, Zeiger MA. Differentiated thyroid cancer. Semin Oncol. 2010; 37(6): 557-66.
- Verburg FA, Lips CJM, Lentjes EGWM, De Klerk JMH. Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it? Br J Cancer. 2004; 91(2): 200-204.
- Schlumberger M, Pacini F, Tuttle RM, Editors. Thyroid Tumors, 4th ed. Paris, France: Institute Medico-Educatif, 2015.
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26(1): 1-133.
- Andergassen U, Zebisch M, Kölbl AC, König A, Heublein S, Schröder L, et al. Real-time qPCR-based detection of circulating tumor cells from blood samples of adjuvant breast cancer patients: A preliminary study. Breast Care. 2016; 11(3):194-198.
- Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C, et al. Detection of circulating thyroid cells in peripheral blood. Surgery. 1996; 120(6): 959-964; discussion 964-965.(?)
- Ringel MD. Molecular detection of thyroid cancer: Differentiating “signal” and “noise” in clinical assays. J Clin Endocrinol Metab. 2004; 89(1): 29-32.
- Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010; 20(12): 1341-1349.
- Gupta MK, Taguba L, Arciaga R, Siperstein A, Faiman C, Mehta A, et al. Detection of circulating thyroid cells by reverse transcription-PCR for thyroid-stimulating hormone receptor and thyroglobulin: the importance of primer selection. Clin Chem. 2002; 48(10): 1862-1865.
- Chinnappa P, Taguba L, Arciaga R, Faiman C, Siperstein A, Mehta AE. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: Sensitive and specific markers for thyroid cancer. J Clin Endocrinol Metab. 2004; 89(8):3705-3709.
- Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001; 25(4):402-408.
- Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2-delta deltaCT method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013; 3(3):71-85.
- Badulescu IC, Barbus E, Piciu D. Circulating tumor cells in thyroid carcinoma – The prognostic role of this biomarker. Review of the literature. Clujul Med. 2017; 90(3):256-261.
- Barzon L, Boscaro M, Paenti M, Taccaliti A, Palu G. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relaps. Int J Cancer. 2004; 110(6): 914-920.
- Wingo ST, Ringel MD, Anderson JS, Patel AD, Lukes YD, Djuh YY, et al. Quantitative reverse trans-cription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem. 1999; 45(6 Pt 1):785-789.
- Teama SH, Agwa SHA, Fawzy A, Sayed MM, Ibrahim WA, Eid YM. Molecular detection of circulating thyroid specific transcripts (TSHR/Tg-mRNAs) in thyroid cancer patients: Their diagnostic significance. Egypt J Med Hum Genet. 2011; 12(2): 201-209.
- Gupta M, Chia SY. Circulating thyroid cancer markers. Curr Opin Endocrinol Diabetes Obes. 2007; 14(5): 383-388.
- Eszlinger M, Neumann S, Otto L, Paschke R. Threoglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of the patients with differentiated thyroid cancer. Eur J Endocrinol. 2002; 147(5): 575-582.
- Ringel MD, Balducci-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, et al. Quantitative reverse transcription-PCR of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab. 1999; 84(11): 4037-4042.
- Bojunga J, Röddiger S, Stanisch M, Kusterer K, Kurek R, Renneberg H, et al. Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR. Br J Cancer. 2000; 82(10): 1650–1655.
- Takano T, Miyauchi A, Yoshida H, Hasegawa Y, Kuma K, Amino N. Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy. Br J Cancer. 2001; 85(1): 102-106.
- Savagner F, Rodien P, Reynier P, Rohmer V, Bigorgne JC, Malthiery Y. Analysis of Tg transcripts by real time RT PCR in blood of thyroid cancer patients. J Clin Endocrinol Metab. 2002; 87(2): 635-639.